Результати пошуку

Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling за авторством Flore Kruiswijk, Sebastian C. Hasenfuss, Renuka Sivapatham, Marjolein P. Baar, Diana A. Putavet, Kishan A.T. Naipal, Niels J. F. van den Broek, Wim H.J. Kruit, Peter J. van der Spek, Dik C. van Gent, Arjan B. Brenkman, Judith Campisi, Boudewijn Burgering, Jan H.J. Hoeijmakers, Peter L.J. de Keizer

Отримати повний текст Отримати повний текст

Identification of MET and SRC Activation in Melanoma Cell Lines Showing Primary Resistance to PLX4032 за авторством Elisabetta Vergani, Viviana Vallacchi, Simona Frigerio, Paola Deho, Piera Mondellini, Paola Perego, Giuliana Cassinelli, Cinzia Lanzi, M. Testi, Licia Rivoltini, Italia Bongarzone, Monica Rodolfo

Отримати повний текст

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia за авторством Enrico Tiacci, Jae H. Park, Luca De Carolis, Stephen S. Chung, Alessandro Broccoli, Sasinya N. Scott, Francesco Zaja, Sean M. Devlin, Alessandro Pulsoni, Young Rock Chung, Michele Cimminiello, Eun Hee Kim, Davide Rossi, Richard M. Stone, Giovanna Motta, Alan Saven, Marzia Varettoni, Jessica K. Altman, Antonella Anastasia, M. R. Grever, Achille Ambrosetti, R. Kanti, Vincenzo Fraticelli, Mario E. Lacouture, Angelo Michele Carella, Ross L. Levine, Pietro Leoni, Alessandro Rambaldi, Franca Falzetti, Stefano Ascani, Monia Capponi, Maria Paola Martelli, Christopher Y. Park, Stefano Pileri, Neal Rosen, Robin Foà, Michael F. Berger, Pier Luigi Zinzani, Omar Abdel‐Wahab, Brunangelo Falini, Martin S. Tallman

Отримати повний текст Отримати повний текст

Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma за авторством Francesco Spagnolo, Paola Ghiorzo, Paola Queirolo

Отримати повний текст Отримати повний текст

Inhibitors of pan-PI3K Signaling Synergize with BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth за авторством Melanie Sweetlove, Emma Wrightson, Sharada Kolekar, Gordon W. Rewcastle, Bruce C. Baguley, Peter R. Shepherd, Stephen M. F. Jamieson

Отримати повний текст Отримати повний текст

Pruritus to anticancer agents targeting the EGFR, BRAF, and CTLA-4 за авторством Alyssa Fischer, Alyx Rosen, Courtney J. Ensslin, Shenhong Wu, Mario E. Lacouture

Отримати повний текст

Mitochondrial oxidative stress is the achille's heel of melanoma cells resistant to Braf-mutant inhibitor за авторством Paola Corazao-Rozas, P. Guerreschi, Manel Jendoubi, Fanny André, Aurélie Jonneaux, C. Scalbert, Guillaume Garçon, Myriam Malet‐Martino, Stéphane Balayssac, Stéphane Rocchi, Ariel Savina, Pierre Formstecher, Laurent Mortier, Jérôme Kluza, Philippe Marchetti

Отримати повний текст Отримати повний текст

Long-term outcome in BRAFV600E melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression за авторством Igor Puzanov, Ravi K. Amaravadi, Grant A. McArthur, Keith T. Flaherty, Paul B. Chapman, Jeffrey A. Sosman, Antoni Ribas, Mark Shackleton, Patrick Hwu, Bartosz Chmielowski, K. B. Nolop, Paul Lin, Kevin B. Kim

Отримати повний текст

Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report за авторством Dae Won Kim, Edelyn Barcena, Urvi Mehta, Michelle Rohlfs, Ashok Kumar, Marta Penas‐Prado, Kevin B. Kim

Отримати повний текст Отримати повний текст

Targeting RAS/RAF/MEK/ERK signaling in metastatic melanoma за авторством Aoxue Wang, Xiaoyi Qi

Отримати повний текст Отримати повний текст

Recent developments in the medical and surgical treatment of melanoma за авторством Vita Saranga‐Perry, Chenwi M. Ambe, Jonathan S. Zager, Ragini R. Kudchadkar

Отримати повний текст Отримати повний текст

Targeting Oncogenic BRAF in Human Cancer за авторством Christine A. Pratilas, Feng Xing, David B. Solit

Отримати повний текст

Acute renal failure associated with the new BRAF inhibitor vemurafenib: A case series of 8 patients за авторством Vincent Launay‐Vacher, Sarah Zimner‐Rapuch, Nicolas Poulalhon, Thibault Fraisse, Valérie Garrigue, Morgane Gosselin, Sabine Amet, Nicolas Janus, Gilbert Deray

Отримати повний текст

PLX4032, a selective BRAF ^V600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF ^WT melanoma cells за авторством Ruth Halaban, Wengeng Zhang, Antonella Bacchiocchi, Elaine Cheng, Fabio Parisi, Stephan Ariyan, Michael Krauthammer, Jamie P. McCusker, Yuval Kluger, Mario Sznol

Отримати повний текст

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort за авторством Oliver Gautschi, Julie Milia, Bastien Cabarrou, M.V. Bluthgen, Benjamin Besse, Egbert F. Smit, Juergen Wolf, Solange Peters, Martin Früh, Dieter Koeberle, Youssouf Oulkhouir, Martin Schüler, Alessandra Curioni‐Fontecedro, Benjamin Huret, M. Kerjouan, Sebastian Michels, Georg Pall, Sacha I. Rothschild, Gerald Schmid‐Bindert, Matthias Scheffler, Rémi Veillon, Luciano Wannesson, Joachim Diebold, Gérard Zalcman, Thomas Filleron, Julien Mazières

Отримати повний текст Отримати повний текст

Vemurafenib resistance reprograms melanoma cells towards glutamine dependence за авторством Jenny E. Hernandez‐Davies, Thai Q. Tran, Michael A. Reid, Kimberly Romero Rosales, Xazmin H. Lowman, Min Pan, Gatien Moriceau, Ying Yang, Jun Wu, Roger S. Lo, Mei Kong

Отримати повний текст Отримати повний текст

Potential clinical implications of<i>BRAF</i>mutations in histiocytic proliferations за авторством Anna-Maria Bubolz, Stephanie E. Weissinger, Albrecht Stenzinger, Annette Arndt, Konrad Steinestel, Silke Brüderlein, Holger Cario, Anneli Lubatschofski, Claudia Welke, Ioannis Anagnostopoulos, Thomas F.E. Barth, Ambros J. Beer, Peter M√oller, M. H. Gottstein, Andreas Viardot, Jochen K. Lennerz

Отримати повний текст Отримати повний текст

Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells за авторством Inna V. Fedorenko, Ethan V. Abel, John M. Koomen, Bin Fang, Elizabeth R. Wood, Y. Ann Chen, Kate Fisher, Sushma Iyengar, Kimberly B. Dahlman, Jennifer A. Wargo, Keith T. Flaherty, Jeffrey A. Sosman, Vernon K. Sondak, Jane L. Messina, Geoffrey T. Gibney, Keiran S.M. Smalley

Отримати повний текст

Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic Melanoma за авторством Giuliana Carlos, Rachael Anforth, Arthur Clements, Alexander M. Menzies, Matteo S. Carlino, Shaun Chou, Pablo Fernández‐Peñas

Отримати повний текст

Severe bilateral panuveitis during melanoma treatment by Dabrafenib and Trametinib за авторством D. Draganova, Joseph Kerger, Laure Caspers, François Willermain

Отримати повний текст Отримати повний текст